Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Van Guilder

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Therapeutic Drug Monitoring|June 13, 2000
Population pharmacokinetics/pharmacodynamics modeling: parametric and nonparametric methodsR Jelliffe, A Schumitzky, M Van Guilder
Statistics in Medicine|February 1, 1989
Estimation of parameters and missing values under a regression model with non-normally distributed and non-randomly incomplete dataS P Azen, M Van Guilder, M A Hill
Therapeutic Drug Monitoring|June 13, 2000
Achieving target goals most precisely using nonparametric compartmental models and "multiple model" design of dosage regimensR Jelliffe, D Bayard, M Milman, et al.
Medinfo. MEDINFO|January 1, 1995
Pharmaco-informatics: more precise drug therapy from 'multiple model' (MM) adaptive control regimens: evaluation with simulated vancomycin therapyR W Jelliffe, D Bayard, A Schumitzky, et al.
Proceedings. Symposium on Computer Applications in Medical Care|January 1, 1994
Pharmaco-informatics: more precise drug therapy from "multiple model" (MM) stochastic adaptive control regimens: evaluation with simulated vancomycin therapyR W Jelliffe, D Bayard, A Schumitzky, et al.
Antimicrobial Agents and Chemotherapy|May 7, 2014
Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapyT W Felton, J A Roberts, T P Lodise, et al.
Therapeutic Drug Monitoring|October 1, 1993
Individualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, Bayesian fitting, and adaptive controlR W Jelliffe, A Schumitzky, M Van Guilder, et al.
Clinical Pharmacokinetics|February 25, 1998
Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new 'multiple model' dosage design, bayesian feedback and individualised target goalsR W Jelliffe, A Schumitzky, D Bayard, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2000
A population pharmacokinetic analysis of the penetration of the prostate by levofloxacinG L Drusano, S L Preston, M Van Guilder, et al.
Antimicrobial Agents and Chemotherapy|July 1, 2015
Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistanceF Docobo-Pérez, G L Drusano, A Johnson, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Therapeutic Drug Monitoring|June 13, 2000
Population pharmacokinetics/pharmacodynamics modeling: parametric and nonparametric methodsR Jelliffe, A Schumitzky, M Van Guilder
Statistics in Medicine|February 1, 1989
Estimation of parameters and missing values under a regression model with non-normally distributed and non-randomly incomplete dataS P Azen, M Van Guilder, M A Hill
Therapeutic Drug Monitoring|June 13, 2000
Achieving target goals most precisely using nonparametric compartmental models and "multiple model" design of dosage regimensR Jelliffe, D Bayard, M Milman, et al.
Medinfo. MEDINFO|January 1, 1995
Pharmaco-informatics: more precise drug therapy from 'multiple model' (MM) adaptive control regimens: evaluation with simulated vancomycin therapyR W Jelliffe, D Bayard, A Schumitzky, et al.
Proceedings. Symposium on Computer Applications in Medical Care|January 1, 1994
Pharmaco-informatics: more precise drug therapy from "multiple model" (MM) stochastic adaptive control regimens: evaluation with simulated vancomycin therapyR W Jelliffe, D Bayard, A Schumitzky, et al.
Antimicrobial Agents and Chemotherapy|May 7, 2014
Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapyT W Felton, J A Roberts, T P Lodise, et al.
Therapeutic Drug Monitoring|October 1, 1993
Individualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, Bayesian fitting, and adaptive controlR W Jelliffe, A Schumitzky, M Van Guilder, et al.
Clinical Pharmacokinetics|February 25, 1998
Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new 'multiple model' dosage design, bayesian feedback and individualised target goalsR W Jelliffe, A Schumitzky, D Bayard, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2000
A population pharmacokinetic analysis of the penetration of the prostate by levofloxacinG L Drusano, S L Preston, M Van Guilder, et al.
Antimicrobial Agents and Chemotherapy|July 1, 2015
Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistanceF Docobo-Pérez, G L Drusano, A Johnson, et al.
Pageof 1